Anastasia Rivkin

Anastasia Rivkin

Dean
School of Pharmacy and Health Sciences

Contact Information

Courses

• Foundations in Integrated Pharmacotherapy I
• An Introduction to Pathophysiology
• Genetics
• Microbiology and Delivery of Care
• Problem Solving & Clinical Decision Making I and II
• Pharmacy Capstone I and II

Research

• Innovative approaches to teaching and learning in pharmacy education
• Faculty development
• Academic leadership
• Gastrointestinal and liver diseases
• Critical care pharmacotherapy
• Drug-induced diseases

Education

• BS, North Dakota State University
• PharmD, North Dakota State University
• EdD, Fairleigh Dickinson University

Academic Profile

Dr. Rivkin received her BS in pharmaceutical sciences and her Doctor of Pharmacy from the College of Pharmacy at North Dakota State University. After completing her residency training at Yale-New Haven Hospital, Dr. Rivkin joined Long Island University Arnold and Marie Schwartz College of Pharmacy and Health Sciences. She worked there for over a decade, starting with a faculty appointment in the division of pharmacy practice. Dr. Rivkin precepted advanced pharmacy practice students for their acute care rotations and provided clinical pharmacy services as a critical care pharmacy specialist at Mount Sinai St. Luke’s Hospital in Manhattan. In the last three years at Long Island University and prior to joining FDU, Dr. Rivkin was leading the Division of Pharmacy Practice as a Division Director. At FDU, Dr. Rivkin has primarily focused on curriculum development and accreditation.  She is the author of multiple peer-reviewed publications that appear in high-impact pharmacy and medical journals. Her work is published in Annals of Pharmacotherapy, American Journal of Pharmaceutical Education (AJPE), American Journal of Health-System Pharmacy, Journal of Critical Care, Pharmacotherapy, Clinical Therapeutics, Currents in Pharmacy Teaching and Learning, Innovations in Pharmacy, Drugs of Today, and Drugs.  Dr. Rivkin is a registered pharmacist in New York and New Jersey. She has been a board-certified pharmacotherapy specialist since 2002. Dr. Rivkin is an active member of the American Association of Colleges of Pharmacy (AACP), the American College of Clinical Pharmacy (ACCP), as well as the New Jersey Pharmacists Association (NJPhA) and the New Jersey Society of Health-System Pharmacist (NJSHP). Dr. Rivkin graduated from the American Association of Clinical Pharmacy leadership and management academy and is a recipient of the John J. Zugich distinguished alumni award through Yale New Haven Health. She serves on the American Journal of Pharmaceutical Education editorial board.